Who decides how much you should pay for your prescription drugs? On this episode Hoji is joined by Anthony Sine and Mona Parsa from Legrande Corporation to discuss how drugs are priced.

Hoji is joined by Krishna Prasad to have a detailed and thoughtful conversation about diabetes and insulin prices. Can we have lower-priced insulin? How can we learn from how other countries manufacture insulin? Krishna heads the site Biological operations at M.J. Biopharm India, which develops and manufactures a range of injectable Diabetes products. We are excited for our listeners to learn from his expertise.

Part of a multi-series discussing the world of microbiology focused on the human immune system and its various defense mechanisms against disease-causing pathogens.

Dr. Akito Ohmura joins Hoji to discuss how different healthcare systems operate, how countries tackle the Covid-19 pandemic, and how crucial technical ISO committees are to the global medical industry.

Hoji and Dr. Southwell will be discussing genetically-designed medicinal solutions, BodySync, improvements in healthcare, and the importance of patient wellness to enhance disease prevention.

In this episode, Hoji will be discussing the challenges entrepreneurs and scientists face when taking a drug from a back-of-a-napkin-idea to a multimillion-dollar company.